Global Fund Lp Lind II Sells 381,676 Shares of ReWalk Robotics Ltd. (NASDAQ:LFWD) Stock

ReWalk Robotics Ltd. (NASDAQ:LFWD) major shareholder Global Fund Lp Lind II sold 381,676 shares of ReWalk Robotics stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $3.36, for a total transaction of $1,282,431.36. Following the completion of the sale, the insider now owns 1,049,430 shares of the company’s stock, valued at $3,526,084.80. This trade represents a 26.67 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

ReWalk Robotics Stock Performance

NASDAQ:LFWD opened at $1.98 on Friday. ReWalk Robotics Ltd. has a fifty-two week low of $1.41 and a fifty-two week high of $8.89. The company has a market cap of $17.44 million, a price-to-earnings ratio of -0.80 and a beta of 2.08. The stock has a fifty day moving average price of $1.95 and a 200-day moving average price of $2.89.

ReWalk Robotics (NASDAQ:LFWD) last announced its quarterly earnings data on Tuesday, November 12th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.08). The firm had revenue of $6.13 million for the quarter, compared to analyst estimates of $8.38 million. ReWalk Robotics had a negative return on equity of 43.02% and a negative net margin of 77.21%. During the same quarter in the previous year, the company earned ($0.56) earnings per share. Research analysts predict that ReWalk Robotics Ltd. will post -1.78 EPS for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in ReWalk Robotics stock. Dimensional Fund Advisors LP purchased a new stake in ReWalk Robotics Ltd. (NASDAQ:LFWD) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 13,548 shares of the company’s stock, valued at approximately $54,000. Dimensional Fund Advisors LP owned about 0.16% of ReWalk Robotics as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 26.76% of the company’s stock.

Wall Street Analyst Weigh In

Separately, HC Wainwright reaffirmed a “buy” rating and set a $13.00 target price on shares of ReWalk Robotics in a report on Wednesday, November 13th.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.